CA2779639A1 - Produits de synthese multivalents pour applications therapeutiques et diagnostiques - Google Patents

Produits de synthese multivalents pour applications therapeutiques et diagnostiques Download PDF

Info

Publication number
CA2779639A1
CA2779639A1 CA2779639A CA2779639A CA2779639A1 CA 2779639 A1 CA2779639 A1 CA 2779639A1 CA 2779639 A CA2779639 A CA 2779639A CA 2779639 A CA2779639 A CA 2779639A CA 2779639 A1 CA2779639 A1 CA 2779639A1
Authority
CA
Canada
Prior art keywords
kdr
binding
group
agent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2779639A
Other languages
English (en)
Inventor
Christophe Arbogast
Philippe Bussat
Daniel T. Dransfield
Hong Fan
Karen E. Linder
Edmund R. Marinelli
Palaniappa Nanjappan
Adrian Nunn
Radhakrishna Pillai
Sybille Pochon
Kondareddiar Ramalingam
Aaron Sato
Ajay Shrivastava
Bo Song
Rolf E. Swenson
Mathew A. Von Wronski
Sharon Michele Walker
Feng Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Suisse SA
Dyax Corp
Original Assignee
Bracco Suisse SA
Dyax Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Suisse SA, Dyax Corp filed Critical Bracco Suisse SA
Priority claimed from CA2477935A external-priority patent/CA2477935C/fr
Publication of CA2779639A1 publication Critical patent/CA2779639A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2779639A 2002-03-01 2003-03-03 Produits de synthese multivalents pour applications therapeutiques et diagnostiques Abandoned CA2779639A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36082102P 2002-03-01 2002-03-01
US60/360,821 2002-03-01
US44020103P 2003-01-15 2003-01-15
US60/440,201 2003-01-15
CA2477935A CA2477935C (fr) 2002-03-01 2003-03-03 Produits de synthese multivalents pour applications therapeutiques et diagnostiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2477935A Division CA2477935C (fr) 2002-03-01 2003-03-03 Produits de synthese multivalents pour applications therapeutiques et diagnostiques

Publications (1)

Publication Number Publication Date
CA2779639A1 true CA2779639A1 (fr) 2003-10-16

Family

ID=46467232

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2779639A Abandoned CA2779639A1 (fr) 2002-03-01 2003-03-03 Produits de synthese multivalents pour applications therapeutiques et diagnostiques

Country Status (1)

Country Link
CA (1) CA2779639A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114740110A (zh) * 2022-03-31 2022-07-12 天津键凯科技有限公司 一种二硬脂酰磷脂酰胆碱纯度的检测方法
CN116570733B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有多功能的核壳壳结构药物胶束及其制备方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114740110A (zh) * 2022-03-31 2022-07-12 天津键凯科技有限公司 一种二硬脂酰磷脂酰胆碱纯度的检测方法
CN114740110B (zh) * 2022-03-31 2023-10-24 天津键凯科技有限公司 一种二硬脂酰磷脂酰胆碱纯度的检测方法
CN116570733B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有多功能的核壳壳结构药物胶束及其制备方法

Similar Documents

Publication Publication Date Title
CA2512780C (fr) Constructions multivalentes permettant de lier le recepteur-2 kdr du vegf pour applications therapeutiques et diagnostiques
US9056138B2 (en) Multivalent constructs for therapeutic and diagnostic applications
US7666979B2 (en) Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
US9629934B2 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
AU2009201114B2 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
CA2477935C (fr) Produits de synthese multivalents pour applications therapeutiques et diagnostiques
WO2006031885A2 (fr) Peptides de liaison a la region du domaine kinase (kdr) et au complexe facteur de croissance endotheliale vasculaire/region du domaine kinase (vegf/kdr)
CA2779639A1 (fr) Produits de synthese multivalents pour applications therapeutiques et diagnostiques

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20181011